A detailed history of ETF Managers Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, ETF Managers Group, LLC holds 11,980 shares of BMY stock, worth $689,808. This represents 0.03% of its overall portfolio holdings.

Number of Shares
11,980
Previous 9,836 21.8%
Holding current value
$689,808
Previous $707,000 17.4%
% of portfolio
0.03%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

BUY
$65.71 - $74.53 $140,882 - $159,792
2,144 Added 21.8%
11,980 $830,000
Q4 2022

Mar 23, 2023

SELL
$68.48 - $81.09 $147,026 - $174,100
-2,147 Reduced 17.92%
9,836 $707,000
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $2,575 - $1.52 Million
-19,812 Reduced 62.31%
11,983 $852,000
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $1.25 Million - $1.38 Million
17,192 Added 117.73%
31,795 $2.47 Million
Q1 2022

May 13, 2022

SELL
$61.48 - $73.72 $192,370 - $230,669
-3,129 Reduced 17.65%
14,603 $1.08 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $12,442 - $14,504
-232 Reduced 1.29%
17,732 $1.11 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $170,942 - $200,236
2,889 Added 19.16%
17,964 $1.08 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $1.52 Million - $1.65 Million
-24,533 Reduced 61.94%
15,075 $999,000
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $1.69 Million - $1.9 Million
28,526 Added 257.41%
39,608 $2.49 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $32,392 - $36,706
561 Added 5.33%
11,082 $681,000
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $327,580 - $363,002
-5,704 Reduced 35.16%
10,521 $630,000
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $127,072 - $148,560
-2,318 Reduced 12.5%
16,225 $938,000
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $609,649 - $885,962
13,139 Added 243.13%
18,543 $1.01 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $68,500 - $89,352
1,392 Added 34.7%
5,404 $344,000
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $3,549 - $4,208
-83 Reduced 2.03%
4,012 $201,000
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $80,271 - $88,762
1,799 Added 78.35%
4,095 $185,000
Q1 2019

May 07, 2019

BUY
$45.12 - $53.8 $9,475 - $11,298
210 Added 10.07%
2,296 $110,000
Q4 2018

Feb 01, 2019

BUY
$48.76 - $63.23 $15,993 - $20,739
328 Added 18.66%
2,086 $108,000
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $10,154 - $11,454
184 Added 11.69%
1,758 $109,000
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $13,946 - $17,382
276 Added 21.26%
1,574 $51,000
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $9,707 - $11,174
162 Added 14.26%
1,298 $80,000
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $9,710 - $10,586
162 Added 16.63%
1,136 $70,000
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $53,794 - $62,082
974
974 $62,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.